Shots:
- Hologic has agreed to be acquired by Blackstone and TPG for up to $79 per share, valuing the deal at up to $18.3B. The deal is expected to close in H1’26
- As per the deal, Blackstone and TPG will acquire all Hologic shares for $76 per share in cash plus a non-tradable CVR worth up to $3 per share in two payments of up to $1.50 each tied to Breast Health revenue goals in FY 2026–2027, totaling up to $79 per share.
- The deal reflects a ~46% premium to Hologic’s May 23, 2025, closing price and includes minority investments from ADIA and GIC. The agreement includes a 45-day go-shop period, allowing Hologic to seek and evaluate alternative bids
Ref: Hologic | Image: Blackstone | Press Release
Related News:- Elanco Inks a $295M Deal with Blackstone for Xdemvy’s Royalties and Milestones, Accelerating Debt Repayment
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
